Introduction
Zygomycosis is an opportunistic fungal infection usually characterized by rapid progression of tissue invasion in patients with haematologic malignancies who have neutropenia and in patients with diabetes mellitus who have ketoacidosis [I, 21 . Recently zygomycosis has been noted in association with therapy with deferoxamine [3-121.
These patients have almost always been on haemodialysis and receiving deferoxamine for iron or aluminium excess states or have had haematologic conditions requiring repeated transfusions with subsequent iron overload treated with deferoxamine chelation. In patients on deferoxamine, as well as those with neutropenia and diabetic ketoacidosis, zygomycosis is almost always rapidly progressive and is usually fatal. We describe a patient who was receiving deferoxamine for myelodysplastic syndrome and who developed indolent zygomycosis manifested by necrotic skin lesions and a right upper lobe pulmonary infiltrate. His infection was treated successfully with amphotericin B. This case extends the clinical spectrum of zygomycosis associated with deferoxamine use. marrow biopsy 3 years earlier and required weekly transfusions since that time to maintain a haematocrit of 26-28%. Twenty months prior to admission he was started on deferoxamine, 1 gram per day, for secondary iron overload. In August 1991, he developed several crusted nodules on his left forearm and abdomen. Biopsy yielded Blastomyces dematitidis. Chest roentgenogram, bone scan, and cultures of other sites revealed no evidence of disseminated disease. He was treated with 400 mg of ketoconazole daily. His lesions resolved within 3 months. Because of gastrointestinal intolerance, he was switched to fluconazole 400 mg daily and it was planned to treat him for a total of 1 year. The transfusions and deferoxamine were continued throughout this time.
O n admission in August 1992, he complained of a non-productive cough, fever, and chills. He denied fatigue, dyspnoea, haemoptysis, or pleuritic pain. His temperature was 37.8 OC, pulse 120 beats min-' , blood pressure 146/56 mmHg. Rales were heard in the right apex, and the rest of the physical examination was within normal limits. The chest roentgenogram showed a right upper lobe infiltrate (Fig. 1) . The white blood cell count was 5700 pl-' with 67% neutrophils, 29% lymphocytes, and 4% monocytes. Cefuroxime was begun for empiric therapy of pneumonia, but the patient remained febrile. Bronchoscopy with brushings and bronchoalveolar lavage, but no biopsy, was negative for mycobacteria, fungi, bacteria, and neoplastic cells. Fluconazole therapy was continued.
One month later the patient was readmitted with progressive swelling, tenderness, and erythema of the right calf in the absence of a history of trauma to the site. He was febrile to 38.4 "C and had a warm, erythematous 8 x 10 cm plaque on his right calf with edema distal to the lesion. The white blood cell count was 4100 pl-' with 65% neutrophils, 29% lymphocytes, 5% monocytes, and 1 '/o myelocytes. Throughout the hospitalization, his serum glucose remained between 150 mg cl-' and 250 mg d-'. The chest radiograph showed no change in the right upper lobe infiltrate. Right lower extremity Doppler studies were negative for venous thrombosis. The patient was treated with intravenous ampicillin/sulbactam for presumed cellulitis without improvement. Punch biopsy of the lesion revealed no pathogens, and repeat bronchoscopy with bronchoalveolar lavage was also negative.
Eleven days later he developed worsening pain and swelling of the right calf. Foul smelling, purulent drainage was present at the site of the previous biopsy ( Fig. 2) . Cultures of the discharge grew coagulase negative staphylococci and group D enterococci. No improvement was noted with vancomycin and ampicillin/sulbactam. Five days later the patient developed 5 dime-sized, tender blueblack lesions on the plantar surface of the right foot and heel (Fig. 3 ). Ten ml of serosanguinous material was aspirated from the calf lesion and culture yielded Rhizopus species. Deferoxamine was discontinued, and intravenous amphotericin B was begun and continued for a total of 2 g with resolution of the lesions on the leg as well as the right upper lobe infiltrate over 6 weeks. The patient's course was complicated by Staphylococcus aureus bacteremia from an indwelling catheter Cutaneous zygomycosk at the site of a pi-evious hiops? requiring treatment with anti-staphylococcal antibiotics and removal of the catheter and superinfection of the calf lesion with enterococci and Pseudomonas, for which he received oral ciprofloxacin. Deferoxamine therapy was restarted 3 months after its discontinuance. Ten weeks after the deferoxamine therapy was re-started, the patient presented with sepsis and acute abdominal pain. Laparotomy revealed ischaemic colon, which was resected. Six weeks later, a splenectomy was performed for a splenic abscess. No fungi were seen or isolated during either operative procedure. He developed a splrnic xtery-duodenal fistula, had recurrent episodes of gam-negative bacterial sepsis and gastrointestinal bleeding, and finally succumbed 15 months aftcr onset of the Rhizopus infection.
Discussion
Zygomycosis refers to infection with fungi of the order Mucorales, which includes, among others, the genera Rhzlopus, Rhzzom ucor, Absadau, Mucor, and Cunnznghamellu. These orgmisms ,are ubiquitous, found in abundance in soil, compost, and mouldy bread and fruit [13] . Despite the prevalence of these organisms and frequent exposure to them, an immunocompetent host effectively prevents their growth so that infection occurs only rarely. ings, which had been contaminated with Rhizopus, and around surgical drains covered with ostomy bags [19, 201 . Still more chronic has been the presentation of isolated cutaneous zygomycosis in patients without preceding trauma or other underlying systemic illnesses [21] .
In all of the reports of cutaneous involvement with the Mucorales, the hallmark has been tissue necrosis. The necrotic calf lesion and the subsequent development of multiple necrotic lesions at a distant site on the heel provided the first clues as to the true nature of our patient's infection. He most likely had involvement of the popliteal or posterior tibia1 artery with subsequent embolization to the smaller arteries of the calcaneal area. The infection in his leg evolved over 6 weeks. In the absence of a history of trauma or the presence of any cutaneous ulcerations at presentation, it appeared most likely that the calf lesion was the result of haematogenous spread from the lung. The chronicity of both the lung and calf lesions were surprising, however, especially in light of his treatment with deferoxamine.
Since the mid 1980s, a new association between zygomycosis and the administration of deferoxamine has received attention. Originally described in haemodialysis patients receiving chelation therapy for aluminum overload, the syndrome has now been documented in approximately 50 patients on haemodialysis and 15 patients with haematologic disorders who received deferoxamine for iron overload [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] 221 . Several explanations have been proposed for the increased susceptibility to zygomycosis in these patients, but it appears most likely that the fungi utilize the deferoxamine as a siderophore to capture iron essential for their growth. Several genera of Mucorales, including Rhizopus, have been shown to produce only small amounts of siderophores for their own use [23] . Human plasma and mucosal surfaces normally contain little free iron, most of it having been sequestered by the iron-binding proteins transferrin and lactoferrin [24] . Thus, deferoxamine can act as an exogenous siderophore for the Mucorales, enabling the fungi to efficiently capture iron in iron-poor environments [25-271. The clinical course of our patient was less fulminant than that described for most patients on deferoxamine therapy. In previous reports of patients with zygomycosis associated with deferoxamine therapy, disseminated or rhinocerebral infection has been most common and the fatality rate has been 88% [3] . It has been suggested that the infection is more rapidly progressive in dialysis patients because of the prolonged half-life of deferoxamine and the iron-deferoxamine chelate in patients with renal failure [27] . On the other hand, infections in patients with haematologic conditions requiring deferoxamine have also had a fulminant course [3] .
Indolent presentations of deferoxamineassociated zygomycosis are rare. Sands et ul., described a patient with beta-thalassemia receiving deferoxamine who developed lymphadenopathy and cutaneous lesions which were due to Cunninghamella bertholletiue and which progressed slowly over 3 months [4] . The course in that patient was similar to that in our patient, and in both patients amphotericin B therapy was successful. We do not know why our patient's course was slowly progressive. It is tempting to speculate that chronic use of fluconazole for treatment of prior infection with B. dennatitidis may have suppressed growth of the organism, but there are no data in humans showing activity of the azoles against the Mucorales [ 131. Generally, it is assumed the azoles have no role in the treatment of zygomycosis. It is also possible that the strain of Rhizopus causing infection was less virulent or less able to use the irondeferoxamine complex as a source of iron for growth [22] .
Therapy of zygomycosis consists of aggressive surgical debridement, correction of any underlying risk factors, and amphotericin B. In those patients receiving deferoxamine, the drug must be stopped. Because of our patient's chronic course, his desire not to have extensive surgical debridement performed, and the absence of progression of the cutaneous and pulmonary lesions on amphotericin B, we treated him with antifungal therapy only. However, in most cases, surgical debridement is essential for resolution of the infection [18, 191. 
